RT @openprescribing: If you have never heard of 👻 Ghost Branded Generics........It's a very nerdy story of how computers impact prescribing…
RT @openprescribing: If you have never heard of 👻 Ghost Branded Generics........It's a very nerdy story of how computers impact prescribing…
RT @openprescribing: If you have never heard of 👻 Ghost Branded Generics........It's a very nerdy story of how computers impact prescribing…
If you have never heard of 👻 Ghost Branded Generics........It's a very nerdy story of how computers impact prescribing. Read the blog https://t.co/cgMaowivuJ or the peer reviewed @BJGPjournal paper https://t.co/rbSemgTgUg
@ciarakirke Read more Blog https://t.co/jxTucSestq Paper https://t.co/DVO66Q7UIT
RT @marcus_baw: Published this month in @BJGPjournal https://t.co/3Hpivw6l0I
RT @marcus_baw: Published this month in @BJGPjournal https://t.co/3Hpivw6l0I
RT @marcus_baw: Published this month in @BJGPjournal https://t.co/3Hpivw6l0I
RT @SarahJPharm: Love this from Brian MacKenna et al @EBMDataLab "one small design choice can have huge ramifications for how GPs prescribe…
RT @SarahJPharm: Love this from Brian MacKenna et al @EBMDataLab "one small design choice can have huge ramifications for how GPs prescribe…
Love this from Brian MacKenna et al @EBMDataLab "one small design choice can have huge ramifications for how GPs prescribe, and the consequent costs to the NHS." Also good to see "Notifying the vendor led to a change in user interface and a rapid, substant
Published this month in @BJGPjournal https://t.co/3Hpivw6l0I
RT @BJGPjournal: Research by Goldacre et al. has uncovered that a design choice in a commonly used EHR has led to £9.5 million in avoidable…
RT @sebbacon: NEW PAPER out. Software professionals know UX decisions can affect the bottom line. What's exciting here is that we can actua…
RT @BJGPjournal: Research by Goldacre et al. has uncovered that a design choice in a commonly used EHR has led to £9.5 million in avoidable…
RT @GLyratzopoulos: useful case study of EHR-design effects @HardeepSinghMD @deansittig : Suboptimal prescribing behaviour associated with…
Now this is worth looking at @MedMgmtProg @INFO_NCPE @CcoHse Is Irish prescribing and/or dispensing software leading to higher and hidden costs?
RT @BJGPjournal: Research by Goldacre et al. has uncovered that a design choice in a commonly used EHR has led to £9.5 million in avoidable…
RT @BJGPjournal: Research by Goldacre et al. has uncovered that a design choice in a commonly used EHR has led to £9.5 million in avoidable…
❗️”There were 31.8M ghost-branded generic items and £9.5M excess cost in 2018, compared with 7.45M ghost-branded generic items and £1.3M excess cost in 2014.” https://t.co/4b9C4vCom5 💡choice architecture can avoid so much 🗑. #behavioraleconomics #informat
Technology needs to enable better prescribing. Save money and time #designthinking
More of this. EHR redesign in response to research findings. "Notifying the vendor led to a change in user interface and a rapid, substantial spend reduction."
Research by Goldacre et al. has uncovered that a design choice in a commonly used EHR has led to £9.5 million in avoidable excess prescribing costs for the NHS in just 1 year. https://t.co/INRgnlLYtv
useful case study of EHR-design effects @HardeepSinghMD @deansittig : Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care https://t.co/JzaQ6pTahM
RT @SuchitaShahUK: A small tweak to SystmOne EHR user interface led to a rapid ⬇️ in spend on ghost-branded generics in UK general practice…
A small tweak to SystmOne EHR user interface led to a rapid ⬇️ in spend on ghost-branded generics in UK general practice. Interesting study in @BJGPjournal https://t.co/J1ajnD8nbJ #uxdesign #healthcare #primarycare #MedEd @NHSX @NHSDigital
RT @openprescribing: Magnificent work by @TPP_SystmOne who responded quickly and implemented a change to the small design choice that we h…
RT @openprescribing: Magnificent work by @TPP_SystmOne who responded quickly and implemented a change to the small design choice that we h…
RT @EBMDataLab: A thread from out CTO on our new paper on Ghost Branded Generics https://t.co/PHJLY5dZ2L
RT @openprescribing: Magnificent work by @TPP_SystmOne who responded quickly and implemented a change to the small design choice that we h…
RT @sebbacon: NEW PAPER out. Software professionals know UX decisions can affect the bottom line. What's exciting here is that we can actua…
RT @EBMDataLab: A thread from out CTO on our new paper on Ghost Branded Generics https://t.co/PHJLY5dZ2L https://t.co/fTZHxzhkyi
RT @inglesp: Fascinating detective work from colleagues... https://t.co/M7fPqAVYIR
RT @EBMDataLab: A thread from out CTO on our new paper on Ghost Branded Generics https://t.co/PHJLY5dZ2L https://t.co/fTZHxzhkyi
RT @inglesp: Fascinating detective work from colleagues... https://t.co/M7fPqAVYIR
A thread from out CTO on our new paper on Ghost Branded Generics https://t.co/PHJLY5dZ2L
Magnificent work by @TPP_SystmOne who responded quickly and implemented a change to the small design choice that we have called "Ghost Branded Generics". Read more in our paper https://t.co/rbSemgTgUg or on our very first blog on the topic! https://t
Fascinating detective work from colleagues...
Our long awaited Ghost Branded Generics paper https://t.co/rbSemgTgUg As always we have tools for coalface clinicians to support improvements! https://t.co/FhgtPo6OY8
NEW PAPER out. Software professionals know UX decisions can affect the bottom line. What's exciting here is that we can actually quantify how (£9.5m in 2018) because of the unique nature of NHS procurement 1/n https://t.co/9gLKgouS7o